PITTSBURGH, Dec. 9, 2013 /PRNewswire/ -- Multi-format food, fuel and pharmacy retailer Giant Eagle, Inc. added to its best-in-class Health and Wellness offerings with the acquisition of Rx21 Specialty Pharmacy, enabling the company to provide enhanced services to Hepatitis C and organ transplant patients and providers.
"At Giant Eagle, we're always looking for ways to expand services and convenience for our customers. We are excited to be able to improve our ability to help patients manage Hepatitis C and transplant conditions with enhanced clinical, operational and mail capabilities," says Senior Vice President of Health and Wellness Brett Merrell. "We greatly value the expertise gained with the new acquisition of Rx21, particularly at a time when two significant new Hepatitis C treatments are becoming available."
Hepatitis C is a viral condition that causes inflammation of the liver and can lead to permanent liver damage, liver cancer, liver failure and cirrhosis. According to the CDC, approximately 3.2 million people in the U.S. have Hepatitis C with almost 17,000 Americans infected each year. Additionally, The US Department of Health and Human Services states that more than 19,000 Americans received transplants from January to August of this year.
Early diagnosis and treatment can help prevent some effects such as liver damage, cirrhosis and even liver cancer in those suffering from Hepatitis C. The CDC recommends Hepatitis C testing for those born between 1945 and 1965, which could prevent more than 120,000 deaths.
The Food and Drug Administration recently approved OLYSIO™ (simeprevir) for use as treatment by those suffering from Hepatitis C, and is expected to approve a similar new drug, sofosbuvir, soon. These medications could offer a more effective approach to treating and eliminating Hepatitis C. Those interested in learning more about the pending Hepatitis
|SOURCE Giant Eagle Inc.|
Copyright©2012 PR Newswire.
All rights reserved